Holen Sie sich die Stockscreener-App
0.3924
6.03%
0.0223
Handel nachbörslich:
.38
-0.0124
-3.16%
Schlusskurs vom Vortag:
$0.3701
Offen:
$0.3676
24-Stunden-Volumen:
724.88K
Relative Volume:
1.25
Marktkapitalisierung:
$23.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-123.46M
KGV:
-0.1515
EPS:
-2.59
Netto-Cashflow:
$-104.11M
1W Leistung:
+4.75%
1M Leistung:
+2.32%
6M Leistung:
-10.00%
1J Leistung:
-71.97%
1-Tages-Spanne:
$0.3601
$0.397
1-Wochen-Bereich:
$0.34
$0.397
52-Wochen-Spanne:
$0.2601
$2.525
Bioatla Inc Stock (BCAB) Company Profile
Firmenname
Bioatla Inc
Sektor
Branche
Telefon
858-558-0708
Adresse
11085 TORREYANA ROAD, SAN DIEGO
Vergleichen Sie BCAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.3924 | 21.73M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-05-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-28 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | BTIG Research | Buy |
| 2021-01-11 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-01-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Bioatla Inc Aktie (BCAB) Neueste Nachrichten
Combining price and volume data for BioAtla Inc.2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - Newser
Can BioAtla Inc. rally from current levelsEntry Point & Free Verified High Yield Trade Plans - Newser
BioAtla downgraded to Market Perform from Outperform at Citizens JMP - TipRanks
BioAtla stock downgraded by Citizens JMP on cash concerns - Investing.com Australia
Has BioAtla Inc. formed a bullish divergence [2025 Institutional Moves]AI Based Buy and Sell Signals - Newser
Will BioAtla Inc. see short term momentum [2025 Market Trends]Accurate Intraday Trading Signals - Newser
Using data filters to optimize entry into BioAtla Inc.Alpha Trade Flow With Risk Calibration - Newser
Why BioAtla Inc. stock attracts strong analyst attentionDay Trading Plan with Entry Risk Management - Newser
BioAtla’s Earnings Call: Positive Clinical Progress Amid Financial Challenges - TipRanks
What technical models suggest about BioAtla Inc.’s comebackFree Portfolio Diversification Stock Ideas - Newser
Analysts Apply Wyckoff Model to BioAtla Inc. StockBuy Low Sell High Stock Watch Strategy in Focus - 선데이타임즈
BioAtla, Inc. (NASDAQ:BCAB) Q2 2025 Earnings Call Transcript - Insider Monkey
Exit strategy if you’re trapped in BioAtla Inc.Alpha Stock Picks with Chart Confirmation - Newser
What makes BioAtla Inc. stock price move sharplyWatchlist Generator for Smart Money Signals - Newser
BioAtla Inc. stock trend outlook and recovery pathFree Stable Entry High Return Opportunities - Newser
Buy Signal for BioAtla Inc. Stock Key Technical Indicators to WatchFree Conservative Entry for High Return Setup - Newser
What institutional flow reveals about BioAtla Inc.Automated AI Forecast with Trading Alerts - Newser
BioAtla Inc. Testing Reversal Zone on Weekly ChartAI Trading Suggestions With Accuracy Focus Released - beatles.ru
Can BioAtla Inc. Outperform Peers After Recent PullbackFundamental + Technical Hybrid Stock Tips Shared - beatles.ru
Does BioAtla Inc. stock have upside surprise potentialDaily Breakout Recap Watch - sisaissue.com
BioAtla, Inc. Reports Q2 2025 Financial Results and Clinical Progress - TipRanks
Head-To-Head Review: Alzamend Neuro (NASDAQ:ALZN) & BioAtla (NASDAQ:BCAB) - Defense World
Sector ETF performance correlation with BioAtla Inc.Free Alpha Driven Watchlist With Alerts - Newser
Comparing BioAtla Inc. in custom built stock radarsFree Swing Setup With Technical Confirmation - Newser
BioAtla's Strategic Position in Immuno-Oncology and Partnership-Driven Growth - AInvest
BioAtla August 2025 slides: promising clinical data amid financial headwinds By Investing.com - Investing.com Nigeria
Earnings call transcript: Bioatla Q2 2025 misses EPS forecasts By Investing.com - Investing.com South Africa
Earnings call transcript: Bioatla Q2 2025 misses EPS forecasts - Investing.com India
BioAtla August 2025 slides: promising clinical data amid financial headwinds - Investing.com
BioAtla Inc Reports Q2 2025 EPS of -$0.32, Missing Estimates; Net Loss at $18.7 Million - AInvest
BioAtla faces Nasdaq delisting over share price rule - MSN
BioAtla Inc (BCAB) Q2 2025 Earnings Call Highlights: Promising Clinical Progress Amid Financial ... By GuruFocus - Investing.com Canada
Bioatla Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : BioAtla, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
BioAtla, Inc. SEC 10-Q Report - TradingView
BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress - The Manila Times
BioAtla Q2 FY23: $ revenue, financial results, conference call August 7, 2025. - AInvest
Top Risks to Consider Before Buying BioAtla Inc. StockBreakout Watcher with Entry and Exit Alerts - Newser
Automated trading signals detected on BioAtla Inc.High Accuracy Trade Setup Identification - Newser
Bioatla Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
Earnings Preview: BioAtla to Report Financial Results Post-market on August 07 - 富途牛牛
BioAtla to Announce Second Quarter 2025 Financial Results and Provide Business Highlights on August 7, 2025 - The Manila Times
Finanzdaten der Bioatla Inc-Aktie (BCAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):